Access count of this item: 353

Files in This Item:
File Description SizeFormat 
45_777.pdf545.08 kBAdobe PDFView/Open
Title: 進行性精巣腫瘍に対する集学的治療の成績
Other Titles: Results of chemotherapy and salvage surgery for advanced testicular cancer
Authors: 細木, 茂  KAKEN_name
目黒, 則男  KAKEN_name
前田, 修  KAKEN_name
木内, 利明  KAKEN_name
黒田, 昌男  KAKEN_name
宇佐美, 道之  KAKEN_name
古武, 敏彦  KAKEN_name
三木, 恒治  KAKEN_name
Author's alias: SAIKI, Shigeru
MEGURO, Norio
MAEDA, Osamu
KINOUCHI, Toshiaki
KURODA, Masao
USAMI, Michiyuki
KOTAKE, Toshihiko
MIKI, Tsuneharu
Keywords: Advanced testicular cancer
Salvage chemotherapy
Issue Date: Nov-1999
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 45
Issue: 11
Start page: 777
End page: 781
Abstract: 1)初期化学療法のみの57例中CRは24例,PRは33例,再燃は8例,長期生存(NED)は52例であった. 2)救済化学療法の16例中CRは1例,PRは12例,PDは3例,再燃は3例,NEDは11例であった. 3)残存組織が壊死に達した24例のNEDは96%,成熟奇形腫(6例)では100%に対して,残存癌(13例)では54%で予後不良であった. 4)腫瘍マーカーが正常化した32例中8例に残存癌が認められたことから化学療法終了時に,残存癌の有無を予測するのは困難で,適切な時期の救済外科療法が重要である. 5)救済外科療法後の再発や,手術不能例の難治性精巣腫瘍19例の治療成績は,集学的治療にも拘わらずNEDが9例であった
Since 1980, 73 patients with advanced testicular cancer have been treated with chemotherapy and 43 patients received post-chemotherapy (salvage) surgery. The median age of all patients was 31 years old, ranging from 17 to 63 years. The histology of the primary testicular tumor was pure seminoma in 23 patients and non-seminoma in 50 patients. According to the Japan Urological Association classification, 38 patients were classified as stage II and 35 patients as stage III. As first-line chamotherapy, 52 patients were treated with PVB regimen (cisplatin, vinblastin, bleomycin), 16 patients with PEB (cisplatin, etoposide, bleomycin) and 5 patients with VAB-6 (vinblastine, actinomycin-D, bleomycin, cisplatin, cyclophosphamide). Thirty (41%) of the 73 patients achieved a complete response (CR) with chemotherapy alone and 63 (86%) achieved no evidence of disease (NED) with salvage treatment. As second-line chemotherapy, 16 patients were treated with PE (cisplatin, etoposide), or VIP (etoposide, ifosfamide, cisplatin) or VeIP (vinblastine, ifosfamide, cisplatin). One of the 16 patients achieved CR and 11 (69%) patients achieved NED. As salvage surgery, retroperitoneal lymphnode dissection (RPLND) was performed in 22 patients, RPLND with thoracotomy in 7 cases and thoracotomy alone in 4 cases. Necrosis was found in surgical specimens of 24 (56%) patients, mature teratoma in 6 (14%) and residual cancer in 13 (30%). Ninety-six percent and 100% of the patients with necrosis and mature teratoma survived with NED, respectively, but only 54% of the patients with residual carcinoma survived despite further treatment. Residual cancer was still found in 8 of the 32 (25%) marker normalized cases. Residual cancer could not reliably be predicted or discriminated from necrosis or mature teratoma by the prognostic criteria. Therefore, salvage surgery remains essential in the treatment of advanced testicular cancer.
URI: http://hdl.handle.net/2433/114156
PubMed ID: 10637743
Appears in Collections:Vol.45 No.11

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.